KRAS and cancer: Approximately 20% of all human cancers harbor RAS mutations (47); KRAS is the most frequently mutated isoform (83%), followed by NRAS (15%), with HRAS mutated infrequently (2%) (GENIE Cohort v17.0; ref. 48).